Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02730598 · ClinicalTrials.gov registry record · NA

Combined Application of Electrical Stimulated Antagonist Contraction During Walking (Walking Study)

A NA study, sponsored by University of Kansas Medical Center.

Completed
Registry status
NA
Development phase
28
Enrollment target

NCT02730598: Completed NA study, sponsored by University of Kansas Medical Center.

NCT02730598 is a NA study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02730598, a NA study, has completed, sponsored by University of Kansas Medical Center.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target

Study Summary

Osteoarthritis of the knee (KOA) is the most common cause of disability in older adults. Osteoarthritis involves a loss of cartilage, which acts like a cushion between the bones as well as changes in the bones of joints. Once the joint cartilage is gone, the body does not produce new cartilage. Joint damage can contribute to pain. Currently, treatment for pain associated with knee osteoarthritis includes exercise. However, exercise at a medium- to high-intensity level can be problematic for people with knee pain. Because exercise is a common treatment for knee pain but many people experience pain during exercise, researchers hope to find a safer and more effective exercise method to strengthen the muscles around the knee. Both aerobic exercise and resistance exercise are recommended for the treatment of people with knee pain. However, pain can be a barrier to participating in exercise at a moderate or vigorous intensity. Electrical stimulation of muscles holds potential to allow effective exercise to be completed at tolerable intensities. Transcutaneous electrical nerve stimulation (TENS) is the use of very low electric currents produced by a device to stimulate the nerves, to treat pain. Neuromuscular electrical stimulation (NMES) uses low electrical current to cause muscles to contract. By doing this study, the investigators hope to learn if a hybrid training system (HTS), using a combination of NMES and walking, is effective in strengthening muscles in people with knee pain, aching or stiffness. In this pilot study, the investigators will use walking with TENS as conventional exercise. Randomized controlled trial will be conducted to compare the effect of walking augmented by HTS with walking without HTS. The investigators will evaluate the relative advantages of training that combines HTS with conventional walking exercise on the improvement of muscle strength, physical function, and pain relief in obese women with frequent knee symptoms. Study Hypotheses:

Primary Outcome

Participants will be familiarized with strength testing equipment and counseled on proper lifting technique. They will undergo testing to determine their peak isokinetic knee extensor torque, using an isokinetic dynamometer.

Interventions

  • DEVICE Hybrid Training System (HTS)
  • DEVICE Sensory TENS

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2016-02
Est. Completion 2017-01-20
Phase NA
University of Kansas Medical Center

408 total trials

What the finished NCT02730598 record still lists

NCT02730598 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Hybrid Training System (HTS) is the first listed.

NCT02730598 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02730598 about?

NCT02730598 is a clinical study titled "Combined Application of Electrical Stimulated Antagonist Contraction During Walking (Walking Study)". Osteoarthritis of the knee (KOA) is the most common cause of disability in older adults. Osteoarthritis involves a loss of cartilage, which acts like a cushion between the bones as well as changes in the bones of joints. Once the joint cartilage is gone, the body does not produce new cartilage. Join...

What is the current status of trial NCT02730598?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2016-02. Estimated completion is 2017-01-20.

What interventions are being tested in trial NCT02730598?

The interventions under investigation include: Hybrid Training System (HTS) (DEVICE), Sensory TENS (DEVICE).

Who is sponsoring clinical trial NCT02730598?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02730598's enrollment target sits among peer trials

28 1704th of 2000 higher than 293 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02730598, the US trial registry maintained by the National Library of Medicine. NCT02730598 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.